TY - JOUR
T1 - Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
AU - Ye, Dezhuang
AU - Chen, Hong
N1 - Funding Information:
This work was supported by the National Institutes of Health (NIH) Grants R01EB027223, R01EB030102 and R01MH116981. It was also partially supported by the Charlie Teo Foundation and Little Legs Foundation. The authors would like to thank Yimei Yue for assisting with the animal experiment, Dr. Jingyi Luan and Dr. Srikanth Singamaneni for providing the 800CW-BSA.
Funding Information:
This work was supported by the National Institutes of Health (NIH) Grants R01EB027223, R01EB030102 and R01MH116981 . It was also partially supported by the Charlie Teo Foundation and Little Legs Foundation. The authors would like to thank Yimei Yue for assisting with the animal experiment, Dr. Jingyi Luan and Dr. Srikanth Singamaneni for providing the 800CW-BSA.
Publisher Copyright:
© 2021 The Authors
PY - 2021/1
Y1 - 2021/1
N2 - The blood-brain barrier (BBB) is the major obstacle for brain drug delivery and limits the treatment options for central nervous system diseases. To circumvent the BBB, we introduce focused ultrasound-mediated intranasal brain drug delivery (FUSIN). FUSIN utilizes the nasal route for direct nose-to-brain drug administration, bypassing the BBB and minimizing systemic exposure to the major organs, such as heart, lung, liver, and kidney [1]. It also uses transcranial ultrasound energy focused at a targeted brain region to induce microbubble cavitation, enhancing the transport of intranasally administered agents at the FUS-targeted brain location. FUSIN is unique because it can achieve noninvasive and localized brain drug delivery with minimized systemic toxicity to other major organs. The goal of this paper is to provide a detailed protocol for FUSIN delivery to the mouse brain. • FUSIN delivery utilizes the nose-to-brain pathway for brain drug delivery. • FUSIN utilizes FUS combined with microbubble to significantly enhance the delivery efficiency of intranasally administered drugs to the FUS targeted brain regions. • FUSIN achieves efficient brain delivery with minimized systemic exposure in the major organs.
AB - The blood-brain barrier (BBB) is the major obstacle for brain drug delivery and limits the treatment options for central nervous system diseases. To circumvent the BBB, we introduce focused ultrasound-mediated intranasal brain drug delivery (FUSIN). FUSIN utilizes the nasal route for direct nose-to-brain drug administration, bypassing the BBB and minimizing systemic exposure to the major organs, such as heart, lung, liver, and kidney [1]. It also uses transcranial ultrasound energy focused at a targeted brain region to induce microbubble cavitation, enhancing the transport of intranasally administered agents at the FUS-targeted brain location. FUSIN is unique because it can achieve noninvasive and localized brain drug delivery with minimized systemic toxicity to other major organs. The goal of this paper is to provide a detailed protocol for FUSIN delivery to the mouse brain. • FUSIN delivery utilizes the nose-to-brain pathway for brain drug delivery. • FUSIN utilizes FUS combined with microbubble to significantly enhance the delivery efficiency of intranasally administered drugs to the FUS targeted brain regions. • FUSIN achieves efficient brain delivery with minimized systemic exposure in the major organs.
KW - Blood-brain barrier
KW - Brain drug delivery
KW - Focused ultrasound
KW - Focused ultrasound-mediated intranasal brain drug delivery technique (FUSIN)
KW - Intranasal administration
KW - Microbubbles
UR - http://www.scopus.com/inward/record.url?scp=85101393691&partnerID=8YFLogxK
U2 - 10.1016/j.mex.2021.101266
DO - 10.1016/j.mex.2021.101266
M3 - Article
C2 - 34434788
AN - SCOPUS:85101393691
SN - 2215-0161
VL - 8
JO - MethodsX
JF - MethodsX
M1 - 101266
ER -